Literature DB >> 17579262

Serotypes, antimicrobial susceptibility, and gyr A gene mutation of Campylobacter jejuni isolates from humans and chickens in Thailand.

Sumalee Boonmar1, Yukio Morita, Masahiro Fujita, Leelaowadee Sangsuk, Karun Suthivarakom, Pawin Padungtod, Soichi Maruyama, Hidenori Kabeya, Masahiko Kato, Kunihisa Kozawa, Shigeki Yamamoto, Hirokazu Kimura.   

Abstract

In Thailand, 51% (36/70) Campylobacter jejuni isolates from humans and 68% (47/69) isolates from poultry were classified into 10 Penner serotypes (serotype B, C, R, E, G, A, K, D, I, and L) and 9 serotypes (serotype A, C, I, K, B, E, S, D, and L), respectively. The rate of antimicrobial drug resistance to nalidixic acid, ciprofloxacin, ampicillin, tetracycline, and erythromycin shown by human isolates were 96%, 96%, 29%, 57%, and 14%, while that shown by poultry isolates were 77%, 77%, 22%, 26%, and 17%, respectively. All quinolone-resistant strains contained a mutation in the gyrA gene (T(86)-->I(86)), suggesting that the strains were already widespread in Thailand.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579262     DOI: 10.1111/j.1348-0421.2007.tb03941.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  High Prevalence of Resistance to Fluoroquinolones and Tetracycline Campylobacter Spp. Isolated from Poultry in Poland.

Authors:  Anna Woźniak-Biel; Gabriela Bugla-Płoskońska; Alicja Kielsznia; Kamila Korzekwa; Anna Tobiasz; Agnieszka Korzeniowska-Kowal; Alina Wieliczko
Journal:  Microb Drug Resist       Date:  2017-06-19       Impact factor: 3.431

2.  PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003.

Authors:  Oralak Serichantalergs; Piyarat Pootong; Anders Dalsgaard; Ladaporn Bodhidatta; Patricia Guerry; David R Tribble; Sinn Anuras; Carl J Mason
Journal:  Gut Pathog       Date:  2010-11-10       Impact factor: 4.181

3.  Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario.

Authors:  Anne E Deckert; Richard J Reid-Smith; Susan E Tamblyn; Larry Morrell; Patrick Seliske; Frances B Jamieson; Rebecca Irwin; Catherine E Dewey; Patrick Boerlin; Scott A McEwen
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Prevalence of Genetic Determinants and Phenotypic Resistance to Ciprofloxacin in Campylobacter jejuni from Lithuania.

Authors:  Jurgita Aksomaitiene; Sigita Ramonaite; John E Olsen; Mindaugas Malakauskas
Journal:  Front Microbiol       Date:  2018-02-14       Impact factor: 5.640

5.  A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries.

Authors:  Tegan N Clarke; Megan A Schilling; Luca A Melendez; Sandra D Isidean; Chad K Porter; Frédéric M Poly
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

6.  Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni.

Authors:  Jing Han; Orhan Sahin; Yi-Wen Barton; Qijing Zhang
Journal:  PLoS Pathog       Date:  2008-06-06       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.